Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension
Open Access
- 21 January 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 47 (5), 1595-1603
- https://doi.org/10.1002/hep.22227
Abstract
Bleeding from esophageal varices (EV) is a serious consequence of portal hypertension. Current guidelines recommend screening patients with cirrhosis with esophagogastroduodenoscopy (EGD) to detect varices. However, the unpleasantness and need for sedation of EGD may limit adherence to screening programs. Pilot studies have shown good performance of esophageal capsule endoscopy in detecting varices. This multicenter trial was designed to assess the diagnostic performance of capsule endoscopy in comparison with EGD. Patients undergoing EGD for screening or surveillance of EV underwent a capsule study previously. The study was designed as an equivalence study, assuming that a difference of ≤10% between capsule endoscopy and EGD in diagnosing EV would demonstrate equivalence. Two hundred eighty‐eight patients were enrolled. Endoscopy was for screening in 195 patients and for surveillance of known EV in 93. Overall agreement for detecting EV between EGD and capsule endoscopy was 85.8%; the kappa score was 0.73. Capsule endoscopy had a sensitivity, specificity, positive predictive value, and negative predictive value of 84%, 88%, 92%, and 77%, respectively. The difference in diagnosing EV was 15.6% in favor of EGD. There was complete agreement on variceal grade in 227 of 288 cases (79%). In differentiating between medium/large varices requiring treatment and small/absent varices requiring surveillance, the sensitivity, specificity, positive predictive value, and negative predictive value for capsule endoscopy were 78%, 96%, 87%, and 92%, respectively. Overall agreement on treatment decisions based on EV size was substantial at 91% (kappa = 0.77). Conclusion: We recommend that EGD be used to screen patients with cirrhosis for large EV. However, the minimal invasiveness, good tolerance, and good agreement of capsule endoscopy with EGD might increase adherence to screening programs. Whether this is the case needs to be determined. (HEPATOLOGY 2008;47:1595–1603.)This publication has 22 references indexed in Scilit:
- Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicatorsHepatology, 2003
- Improved Patient Survival After Acute Variceal Bleeding: A Multicenter, Cohort StudyThe American Journal of Gastroenterology, 2003
- Complications of upper GI endoscopyGastrointestinal Endoscopy, 2002
- NATURAL HISTORY OF PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSISClinics in Liver Disease, 2001
- A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleedingHepatology, 2001
- Updating Consensus in Portal Hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertensionJournal of Hepatology, 2000
- Pharmacological Treatment of Portal Hypertension: An Evidence-Based ApproachSeminars in Liver Disease, 1999
- Portal hypertension and variceal bleeding: An AASLD single topic symposiumHepatology, 1998
- Developing consensus in portal hypertensionJournal of Hepatology, 1996
- Prediction of the First Variceal Hemorrhage in Patients with Cirrhosis of the Liver and Esophageal VaricesThe New England Journal of Medicine, 1988